Business
AstraZeneca and Johnson & Johnson given green light to resume US coronavirus vaccine trials – ABC News
In a sign of progress in the race to develop a vaccine for COVID-19, AstraZeneca’s resumption of its US clinical trial is set to be soon followed by Johnson & Johnson…
AstraZeneca has resumed the US trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial early next week.
Key points:
- Both vaccine candidates had been forced to pause US trials after participant illnesses
- But both have been cleared to resume after it was found the vaccines were not the cause
- The race for a vaccine comes as coronavirus infections rise in dozens of countries
The news signalled progress against the novel coronavirus…
Continue Reading
-
General21 hours agoA feeling of calm before the storm descends on Tasmanian politics following motion of no-confidence in Jeremy Rockliff
-
Business24 hours agoWhat did Macquarie’s “FOMO Meter” reveal about the stock market in May?
-
Noosa News20 hours agoForty years inside a Brisbane second-hand store
-
Noosa News17 hours agoMan dies, another injured after structure collapses at Inala residence in southwest Brisbane